Cancer Research UK-funded scientists have made an unusual discovery that could help to identify patients who are up to two and a half times more likely to respond to currently available cancer drugs.
<p>26 scientists have been selected to join the EMBO Young Investigator Programme, an initiative that supports excellent young group leaders in the early stages of their independent careers.</p>